Current Vascular Pharmacology

Editor-in-Chief:

Dimitri P. Mikhailidis  
Academic Head, Department of Clinical Biochemistry
Royal Free Hospital Campus
University College London Medical School
University College London (UCL)
Pond Street, London, NW3 2QG
UK

Back

Become EABM
Become Reviewer

Reactive Oxygen Species, Vascular Disease and Cardiovascular Surgery

Volume:2   Issue: 3
Pp: 229-236
Jamie Y. Jeremy, Nilima Shukla, Saima Muzaffar, Alexandra Handley and Gianni D. Angelini
DOI: 10.2174/1570161043385691

Diabetic Cardiomyopathy: Electromechanical Cellular Alterations

Volume:2   Issue: 3
Pp: 237-248
O. Casis and E. Echevarria
DOI: 10.2174/1570161043385655

Endothelin-1 and Endothelin Converting Enzyme-1 in Human Atherosclerosis - Novel Targets for Pharmacotherapy in Atherosclerosis

Volume:2   Issue: 3
Pp: 249-258
C. Ihling, B. Bohrmann, H. E. Schaefer, K. Technau-Ihling and B. M. Loeffler
DOI: 10.2174/1570161043385718

Recent Progress on Tumor Missile Therapy and Tumor Vascular Targeting Therapy as a New Approach

Volume:2   Issue: 3
Pp: 259-270
Yasuo Yoshioka, Yasuo Tsutsumi, Shinsaku Nakagawa and Tadanori Mayumi
DOI: 10.2174/1570161043385682

Endothelial Endocytic Pathways: Gates for Vascular Drug Delivery

Volume:2   Issue: 3
Pp: 281-299
Silvia Muro, Michael Koval and Vladimir Muzykantov
DOI: 10.2174/1570161043385736

Update in the Management of Diastolic Heart Failure

Volume:2   Issue: 3
Pp: 301-308
Cheuk-Man Yu and John E. Sanderson
DOI: 10.2174/1570161043385619